Description: The Source NASDAQ Biotech UCITS ETF aims to provide the performance of the NASDAQ Biotechnology Index1 (the “Benchmark Index”). The Benchmark Index is designed to represent the performance of biotechnology and pharmaceutical securities on the NASDAQ Stock Market.
Exchange: LSE
Country: UK : United Kingdom
Currency: US Dollar ($)
Category: Sector Equity Biotechnology
| Asset Allocation | |||
|---|---|---|---|
| Asset Class | Long % | Short % | Net Assets |
| Stock US | 89.57 | 0.00 | 89.57 |
| Stock non-US | 10.43 | 0.00 | 10.43 |
| Sector Weights | ||
|---|---|---|
| Sector | Equity % | Relative to Category |
| Healthcare | 100.00 | 99.95 |
| World Regions | ||
|---|---|---|
| Region | Equity % | Relative to Category |
| North America | 90.35 | 86.85 |
| United Kingdom | 3.96 | 2.20 |
| Europe Developed | 3.84 | 7.33 |
| Asia Emerging | 1.73 | 2.50 |
| Asia Developed | 0.08 | 0.32 |
| Africa/Middle East | 0.04 | 0.02 |
| Japan | 0.00 | 0.63 |
| Australasia | 0.00 | 0.14 |